Time:
All Today Tomorrow This Week This Month

Gene and Cell Therapy Solutions in Cancer Therapy Research

Despite hundreds of off-the-shelf treatments, cancer remains one of the leading cause of death globally

10-28-2021 Dr. Edward Wong, Dr. Leung How Wing

Learn More

High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics

In this webinar, Dr. Ming Ni, the CMC Project Manager for ProBio will provide a high-level overview of his experience in dealing with the challenges of plasmid production.

10-27-2021 Dr. Ming Ni, the CMC Project Manager for ProBio

Learn More

Customized CMC development strategy for recombinant protein

In this webinar, Leon Tian will detail ProBio’s experience and understanding in dealing with recombinant protein challenges.

10-25-2021 Senior Project Manager Dr. Leon Tian

Learn More

Tracing oncogene-driven remodeling of the intestinal stem cell niche

Interactions between tumor cells and the surrounding microenvironment contribute to tumor progression, metastasis and recurrence.

10-04-2021 Dr. Bon-Kyoung Koo, Group Leader, Institute of Molecular Biotechnology of Austrian Academy of Sciences (IMBA), Vienna, Austria

Learn More

Stable intronic sequence RNA (sisRNA): an expanding universe

Why do eukaryotic cells have introns? Our genes are frequently interspersed with noncoding introns that are commonly believed to be “junk” because they are highly unstable after splicing.

09-23-2021 Dr. Pek Jun Wei, Principal Investigator, Temasek Life Science Laboratory, Singapore

Learn More

Suppression of replication-competent SARS-CoV-2 variants with reprogrammed CRISPR-Cas13b

The COVID-19 pandemic has emerged as a catastrophic global emergency. The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and

09-15-2021 Dr. Mohamed Fareh, Senior Research Fellow, Peter MacCallum Cancer Centre

Learn More

< 7 8 9 10 11 12 13 14 15 16 17 > Total Pages 35